Investegate announcements from COMPASS Pathways, COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
Wall Street analysts expect COMPASS Pathways plc (NASDAQ:CMPS – Get Rating) to announce earnings of ($0.68) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for COMPASS Pathways’ earnings, with the highest EPS estimate coming in at ($0.65) and the lowest estimate coming in at ($0.73). COMPASS Pathways […]
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $13.37, but opened at $14.48. COMPASS Pathways shares last traded at $14.18, with a volume of 362 shares. CMPS has been the topic of a number of analyst reports. Zacks Investment Research […]